NCT04226144

Brief Summary

it will be conducted a randomized parallel controlled trial with patients diagnosed with Amyotrophic Lateral Sclerosis (ALS) to compare two techniques to lung recruitment and cough augmentation, to assess their effects on pulmonary function, global functionally, swallowing and ability to speech in these population.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 6, 2020

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

January 9, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 13, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2021

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

April 4, 2023

Status Verified

April 1, 2023

Enrollment Period

1.7 years

First QC Date

January 9, 2020

Last Update Submit

April 1, 2023

Conditions

Keywords

respiratory function testsdeglution disorders

Outcome Measures

Primary Outcomes (3)

  • maximal respiratory pressures

    change of decline rate of maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) assessed by digital pressure (MVD-500 V.1.1 Microhard System,Porto Alegre, Brazil).

    from baseline to 24 weeks

  • Peak cough flow

    change of decline rate of peak cough flow (PCF) assessed by analogic peak cough flow meter (Respironics-Philips Health Care,PA,USA)

    from baseline to 24 weeks

  • Forced Vital Capacity and Slow Vital Capacity

    Change of decline rate of Forced Vital Capacity (FVC) and Slow Vital Capacity (SVC) predicted by brazilian population assessed by digital spirometer (Vitalgraph, London, UK)

    from baseline to 24 weeks

Secondary Outcomes (3)

  • ALSFR-BR

    from baseline to 24 weeks

  • Voice parameters

    from baseline to 24 weeks

  • swalloing function

    from baseline to 24 weeks

Study Arms (2)

Breath Stacking Group

ACTIVE COMPARATOR

The lungs are inflated as fully as possible by stacking successive breaths without expiration until the patients' maximal inspiratory capacity (MIC). The participant will be instructed to sustain the air in the lung, closing the glottis. Once the lungs are maximally inflated, the compressed air volume is released under expiratory muscle force, thus generating a cough with lung and chest wall recoil. They will perform 5-8 cycles of breath stacking per session, stacking 3-5 breaths per cycle.

Device: Breath Stacking Group

Breath stacking and EMT

EXPERIMENTAL

This group will perform the breath stacking technique in addiction with EMT. It will change the one-way valve in this group to VUP (Lumiar, Sao Paulo, Brazil) one-way valve, which allows the patients blow out the air with a counter resistance during all expiratory phase. The initial expiratory pressure will be 8 cmH2O, and could be changed at each visit according to participants' tolerance (either report easy or difficult to exhale assessed by research coordinators. The participants are encouraged to blow out the most slowly that they can do it.

Device: Breath stacking and EMT

Interventions

Lung recruitment technique using manual bag resuscitation with oronasal mask interface

Also known as: lung recruitment technique
Breath Stacking Group

Lung recruitment technique with one way valve with counter resistance during all expiratory phase

Also known as: VUP
Breath stacking and EMT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of neuromuscular disease confirmed by neurologists at the referral center for neuromuscular diseases at Brasília prior to screening for recruitment
  • age over 18 years
  • preserved cognition, evidenced by a score greater than or equal to 24 points in the Mini-Mental Status Exam;
  • no barium allergies
  • without tracheostomy or invasive mechanical ventilation
  • no diaphragmatic pacemaker
  • without associated respiratory disease

You may not qualify if:

  • pregnancy
  • previous kidney disease or other concomitant diseases .respiratory diseases and hospitalization in intensive care units (ICUs) during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de Apoio de Brasilia

Brasília, Federal District, 700000, Brazil

Location

Related Publications (1)

  • Dorca A, Alcantara LA, Diniz DS, Sarmet M, Menezes Mateus SR, Franco Oliveira LV, Franco H, Maldaner V. Comparison between breath stacking technique associated with expiratory muscle training and breath stacking technique in amyotrophic lateral sclerosis patients: Protocol for randomized single blind trial. Contemp Clin Trials Commun. 2020 Sep 2;19:100647. doi: 10.1016/j.conctc.2020.100647. eCollection 2020 Sep.

MeSH Terms

Conditions

Amyotrophic Lateral SclerosisNeuromuscular Diseases

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesMotor Neuron DiseaseNeurodegenerative DiseasesTDP-43 ProteinopathiesProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Vinicius Maldaner

    Hospital de Apoio de Brasilia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: two-arm, parallel (1:1), superiority, blinded-assessor randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PT, PhD

Study Record Dates

First Submitted

January 9, 2020

First Posted

January 13, 2020

Study Start

January 6, 2020

Primary Completion

August 31, 2021

Study Completion

December 1, 2022

Last Updated

April 4, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations